Autolus Therapeutics Announces Stock Option Grants to Employees Under Nasdaq Listing Rule 5635(c)(4)

Autolus Therapeutics has announced the grant of 113,650 stock options to 22 employees under the 2025 Inducement Plan. The options have a grant date of January 26, 2026, an exercise price of $1.46, and a ten-year term. The options vest over four years, with 25% vesting on the one-year anniversary and the remainder vesting in 36 equal monthly installments.